The first round of Seed Funding opened for competitive applications on 25 September 2018 and closed on 28 October 2018.  Eight applications were received and reviewed by the working group. The working group recommended that three applications be funded, and this was ratified by the Board at their meeting on 5 December 2018.

Total grant funding awarded in Round 1 Seed Funding was $196,137.50.

Emerging Drugs Network of Australia

Amount awarded: $100,000.00

Principal Investigator: Dr Jessamine Soderstrom, Royal Perth Hospital.

ANZCTR Link

Increasing the capacity of a local health district to respond to methamphetamine-related harm: developing an integrated model of care informed by linked data

Amount awarded: $66,190.00

Principal Investigator: Dr Briony Larance, University of Wollongong.

Sentinel surveillance for emerging illicitly manufactured fentanyl use in an inner-city opioid agonist treatment service

Amount awarded: $29,947.00

Principal Investigator: Dr Craig Rodgers, St Vincent’s Hospital Sydney